Business Wire

Aqara Announces Global Availability of Smart Lock U200

9.7.2024 10:00:00 EEST | Business Wire | Press release

Share

Aqara, a global leader and pioneer in IoT, today announced the official launch of the highly anticipated Smart Lock U200. Designed as a retrofit, keyless solution for home access management, the U200 lock offers unparalleled convenience, advanced security features, and seamless interoperability across smart home ecosystems and devices thanks to its native Matter compatibility.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240709404547/en/

Aqara Smart Lock U200 (Photo: Business Wire)

The Aqara Smart Lock U200 brings a modern keyless lifestyle to a broad array of homeowners and renters, and provides multiple secure door entry options, including Apple home keys, which allow iOS users to unlock effortlessly by tapping a compatible iPhone or Apple Watch. The U200 distinguishes itself as one of the first Matter-over-Thread locks to support home key unlocking and is also one of the first retrofit smart locks to feature Apple home key.

Other unlocking methods of the Smart Lock U200 include:

  • Fingerprint recognition: Fast and secure access with the high-precision fingerprint reader.
  • PIN codes: Personalized codes can be entered on the included, pre-paired wireless keypad. Moreover, Aqara Home users can manage guess access easily with not only periodic passwords but also one-time passwords that can be remotely created, shared, and used even when the lock is disconnected from any platforms.
  • Mobile apps and voice assistants: Remote control via Aqara Home, Alexa, Apple Home/Siri, Google Home/Google Assistant, SmartThings, Home Assistant, and more1.
  • Aqara NFC cards: Quick and easy unlocking using Aqara’s NFC key fobs2.
  • Traditional keys: emergency access with the original keys.

The U200 lock stands out with its hassle-free retrofit design, allowing homeowners and renters to upgrade their existing locks - such as Euro mortise locks and US deadbolt locks - without the need to change keys or modify the door structure. This lock provides an instant smart update to most homes and is suitable for DIY installation, as attaching the U200 over the existing lock is simple and requires no tool apart from a screwdriver.

Security is a top priority with the Smart Lock U200. It features advanced encryption to protect against hacking, a tamper alarm on the wireless keypad, and an auto-lock function that secures the door automatically after a set period. Additionally, the U200 provides real-time notifications to keep users informed about their home’s security status.

The U200 retains many popular features of the previous Aqara locks, such as local and encrypted storage of sensitive data like fingerprints and passwords, anti-peep PIN code protection, Do-Not-Disturb mode, Passage mode, and Night Latch mode3. Furthermore, it adds thoughtful features like quiet unlock mode to minimize the noise level, pull spring feature for handle-less or inward-opening doors, as well as turn-to-lock and turn-to-unlock functions.

Built upon the energy-efficient Thread protocol, the U200 lock is designed for extended use. The lock runs on rechargeable Li-Ion batteries and boasts a battery life of up to 6 months between each charge. Additionally, the IPX5-rated wireless keypad is operable with AAA batteries or existing doorbell wiring, which allows for uninterrupted usage4.

The Smart Lock U200 is now available at Aqara’s Amazon brand stores throughout North America (US, Canada) and Europe (France, Germany, Italy, Netherlands, Poland, Spain, UK), as well as through select Aqara retailers worldwide.

The U200 lock is compatible with Euro mortise locks with Emergency Function, and supports various cylinders including EU profile cylinders, select Scandi profile cylinders and UK oval cylinders. An Emergency Function enables the cylinder to be unlocked from the outside using a key, even if another key is already inserted on the inside. Adjustable cylinders are sold separately by Aqara. The U200 is also compatible with single-cylinder deadbolt locks.

For more information on the U200 lock and its compatibility, please visit our website.

  1. A Matter controller with Thread Border Router functionality is required to connect the Smart Lock U200 to any third-party Matter-enabled system.
  2. Aqara NFC card is available in-box with the Smart Lock U200 Kit or sold separately.
  3. Some of these features may not be available at the time of launch, and will be added via subsequent OTA updates.
  4. The 6-month battery life is based on the assumption of 8 cycles of unlocking and locking per day. To operate the wireless keypad with the existing doorbell wiring, a 12V-24V AC/DC power supply is required.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240709404547/en/

Contacts

For Media Inquiries:
media@aqara.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Industrial Decarbonization: Calderion, WenCo and Terravent Invest in Graforce to Scale Plasma Pyrolysis Globally25.2.2026 09:07:00 EET | Press release

The investor consortium comprising the Paris-based Next Generation Fuels Industrial & Technological fund Calderion (Audacia), alongside infrastructure developer Terravent and WenCo Family Office, announces the closing of a strategic double-digit million-euro financing round for Berlin-based Graforce GmbH. The investment is dedicated to the industrial scale-up of Graforce’s proprietary plasma pyrolysis technology, addressing the growing global demand for cost-efficient low-carbon hydrogen, syngas, and carbon removal solutions that are compatible with existing industrial infrastructures. Disruptive alternative to conventional processes Graforce’s technology aims at replacing CO₂-intensive legacy routes such as steam reforming and classical gasification. By applying plasma to methane, biogas, flare gas, and landfill gas, the process converts these streams into their valuable molecular components instead of emitting them. The result is a high-efficiency production of clean hydrogen and syn

Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy25.2.2026 09:00:00 EET | Press release

Mevion Medical Systems, the global leader in compact proton therapy, today announced that the MEVION S250-FIT Proton Therapy System has successfully completed the conformity assessment process and has received CE Marking under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone enables the marketing, sale, and clinical use of the MEVION S250-FIT system throughout the European Union, building on the system’s existing U.S. FDA 510(k) clearance granted in September 2025. The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION S250-FIT dramatically reduces the cost, complexity, and timeline traditionally associated with proton therapy adoption. This opens a new pathway for hospitals and cancer centers across Europe to bring advanced proton treatment to their patients. “With both FDA clearance and CE Marking now in hand, the MEVION S250-FIT is

Bureau Veritas: Sector-Leading Organic Revenue Growth of 6.5% in FY 202525.2.2026 08:30:00 EET | Press release

Bureau Veritas (BOURSE:BVI): 2025 key figures1 › Full-year revenue of EUR 6,466.4 million, up 6.5% organically (with 6.3% organic growth in Q4). At constant currency, the growth was up 7.3% year-on-year and up 3.6% on a reported basis, › Adjusted operating profit of EUR 1,052.9 million, up 5.7% versus EUR 996.2 million in FY 2024, representing an adjusted operating margin of 16.3%, up 32 basis points year-on-year and up 51 basis points at constant currency, › Operating profit of EUR 992.4 million, up 6.3% versus EUR 933.4 million in FY 2024, › Adjusted net profit of EUR 631.4 million, up 1.7% versus EUR 620.7 million in FY 2024, › Adjusted EPS stood at EUR 1.42 in 2025, with a 2.8% increase versus FY 2024 (EUR 1.38 per share) and up 9.2% at constant currency, › Attributable net profit of EUR 588.0 million, up 3.3% versus EUR 569.4 million in FY 2024, › Free Cash Flow of EUR 824.2 million, up 3.9% organically and up 2.6% at constant currency, and cash conversion of 107%2, › Adjusted net

Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis25.2.2026 08:00:00 EET | Press release

Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept preclinical data with its lead product, nizubaglustat, in GM2 gangliosidosis. The data, published in the 7 January issue of the Journal of Inherited Metabolic Disease in collaboration with the laboratory of Dr. Jagdeep Walia, Department of Pediatrics, Queen's University, Kingston, Canada, reinforce nizubaglustat’s potential to address unmet needs in rare LSDs and build on existing preclinical and clinical evidence. The preclinical study tested nizubaglustat in a mouse model in Sandhoff disease, a form of GM2 gangliosidosis with no approved treatments—alongside healthy control subjects. The research assessed how the drug’s exposure relates to its effects in the brain, demonstrating a significant increase in both survival (22%; 26 days) and assessments of movement and behavior at 16 weeks versus un

Galderma Announces Triple Approval of New State-of-the-Art Restylane ® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics25.2.2026 08:00:00 EET | Press release

Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-art syringe for use with its NASHA® lidocaine range of Restylane products in multiple facial indications including the cheeks, nose, chin, jawline, tear troughs, nasolabial folds, marionette lines, as well as in the hands.1-3 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224651688/en/ The syringe features a next-generation ergonomic design that enhances precision and control; includes an optimized syringe-needle connection with the new Terumo K-Pack Enhance™ needle; and offers a premium color-coded packaging and syringe design to support easy range navigation for practitioners.4-7, 9,10 It sets a new standard in Injectable Aesthetic devices and demonstrates Galderma’s unwavering commitment to driving innovation to meet the needs of both practitioners and patients. “Developing this new syringe

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye